Influenza hemagglutinin subunit vaccines are more effective and offer better cross protection against various influenza virus ...

For recombinant protein vaccine developers, this includes access to effective GMP-grade adjuvants, which have been known to cause bottlenecks in production. Therefore, ...

Biological E partners with China’s Recbio to produce REC603 a 9-valent HPV vaccine in India The collaboration aims to expand ...

The growth of the recombinant proteins market is driven by advancements in biopharmaceutical research, increasing demand for personalized medicin ...

The result is what’s known as a “recombinant protein vaccine.” It’s made without live or dead versions of H5N1, relying on bits of genetic material from the virus to trigger the mouse’s ...

The global biologics market is estimated to be valued at USD 450.2 billion in 2025 and is projected to reach USD 1,077.2 billion by 2035, registering a CAGR of 9.1% over the forecast period. The ...

Recombinant therapeutics market surges to $960.4B by 2035, fueled by biotech advances, targeted therapies, and rising global ...

The newest, updated Covid-19 vaccines are now FDA-approved and available, including the mRNA ones from Pfizer-BioNTech and Moderna and the recombinant one from Novavax.

Loopworm, a Bengaluru-based biomanufacturing company developing insect-derived proteins, has raised $3.25 million Pre-Series ...

Bharat Biotech has entered into partnership in 2021 to produce part of the malaria vaccine that has been developed by British ...